Patents Assigned to Genani Corporation
  • Methods for improving cognition and slowing cognitive impairment using nonviable lyophilized pluripotent stem cells
    Patent number: 10828338
    Abstract: The disclosure is directed to the use of nonviable pluripotent stem cells to improve age-related declines in tissue and organ function. In one aspect, nonviable pluripotent stem cells are used to improve cognition in a subject in need thereof. In another aspect, nonviable pluripotent stem cells are used to improve age-related cardiac dysfunction in a subject in need thereof. Administration of nonviable pluripotent stem cells provides a transient and safe form of heterochronic cellular transbiosis.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: November 10, 2020
    Assignee: Genani Corporation
    Inventor: Richard K. Burt
  • Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells
    Patent number: 10813955
    Abstract: The disclosure is directed to the use of nonviable pluripotent stem cells to improve age-related declines in tissue and organ function. In one aspect, nonviable pluripotent stem cells are used to improve cognition in a subject in need thereof. In another aspect, nonviable pluripotent stem cells are used to improve age-related cardiac dysfunction in a subject in need thereof. Administration of nonviable pluripotent stem cells provides a transient and safe form of heterochronic cellular transbiosis.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: October 27, 2020
    Assignee: Genani Corporation
    Inventor: Richard K. Burt